Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-04-08 16:44:12 ET · period of report 2026-04-07 · accession 0001835458-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-08 16:44 | 2026-04-07 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +2,694 | 17.5K | +18% | — |
| D | 2026-04-08 16:44 | 2026-04-07 | KNSA | Ragosa Mark | CFO | F - Tax | $48.94 | -1,303 | 16.2K | -7% | -$63.8K |
| D | 2026-04-08 16:44 | 2026-04-07 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -2,694 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-04-07 | M | A | 2,694 | — | 17,457 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Common | Class A Ordinary Share | 2026-04-07 | F | D | 1,303 | $48.94 | 16,154 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2026-04-07 | M | D | 2,694 | $0.00 | 0 | D | — · — to — | 2,694 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. |